spacer
spacer

PDBsum entry 1q02

Go to PDB code: 
protein links
Protein binding PDB id
1q02

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
52 a.a. *
* Residue conservation analysis
PDB id:
1q02
Name: Protein binding
Title: Nmr structure of the uba domain of p62 (sqstm1)
Structure: Sequestosome 1. Chain: a. Fragment: uba domain. Synonym: ubiquitin-binding protein p62, sqstm1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
NMR struc: 27 models
Authors: B.Ciani,R.Layfield,J.R.Cavey,P.W.Sheppard,M.S.Searle
Key ref:
B.Ciani et al. (2003). Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. J Biol Chem, 278, 37409-37412. PubMed id: 12857745 DOI: 10.1074/jbc.M307416200
Date:
15-Jul-03     Release date:   30-Sep-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q13501  (SQSTM_HUMAN) -  Sequestosome-1 from Homo sapiens
Seq:
Struc:
440 a.a.
52 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 

 
DOI no: 10.1074/jbc.M307416200 J Biol Chem 278:37409-37412 (2003)
PubMed id: 12857745  
 
 
Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone.
B.Ciani, R.Layfield, J.R.Cavey, P.W.Sheppard, M.S.Searle.
 
  ABSTRACT  
 
The p62 protein (also known as SQSTM1) mediates diverse cellular functions including control of NFkappaB signaling and transcriptional activation. p62 binds non-covalently to ubiquitin and co-localizes with ubiquitylated inclusions in a number of human protein aggregation diseases. Mutations in the gene encoding p62 cause Paget's disease of bone (PDB), a common disorder of the elderly characterized by excessive bone resorption and formation. All of the p62 PDB mutations identified to date cluster within the C-terminal region of the protein, which shows low sequence identity to previously characterized ubiquitin-associated (UBA) domains. We report the first NMR structure of a recombinant polypeptide that contains the C-terminal UBA domain of the human p62 protein (residues 387-436). This sequence, which confers multiubiquitin chain binding, forms a compact three-helix bundle with a structure analogous to the UBA domains of HHR23A but with differences in the loop regions connecting helices that may be involved in binding accessory proteins. We show that the Pro392 --> Leu PDB substitution mutation modifies the structure of the UBA domain by extending the N terminus of helix 1. In contrast to the p62 PDB deletion mutations that remove the UBA domain and ablate multiubiquitin chain binding, the Pro392 --> Leu substitution does not affect interaction of the UBA domain with multiubiquitin chains. Thus, phenotypically identical substitution and deletion mutations do not appear to predispose to PDB through a mechanism dependent on a common loss of ubiquitin chain binding by p62.
 
  Selected figure(s)  
 
Figure 1.
FIG. 1. a, domain structure of the p62 protein and Paget's disease of bone mutation sites (SH2, AID, ZZ, and TRAF6 refer to binding sites for the SH2 domain of p56^lck, aPKC, RIP, and TRAF6, respectively), and b, sequence alignment of the p62-UBA domain with the HHR23A-UBA domains (alignment from SMART data base; see Ref. 7).
Figure 3.
FIG. 3. a, ribbon structure of the p62-UBA domain with key side chains highlighted with MOLMOL (30); b, overlaid backbone of the p62-UBA (light) and UBA (2) of HHR23A (dark) (Protein Data Bank code 1DV0 [PDB] ) showing the helical alignment and differences in loop 1 incorporating Glu409 and Gly410 in p62.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2003, 278, 37409-37412) copyright 2003.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20635090 K.Seidel, W.F.den Dunnen, C.Schultz, H.Paulson, S.Frank, R.A.de Vos, E.R.Brunt, T.Deller, H.H.Kampinga, and U.Rüb (2010).
Axonal inclusions in spinocerebellar ataxia type 3.
  Acta Neuropathol, 120, 449-460.  
20839008 P.Y.Chung, G.Beyens, S.Boonen, S.Papapoulos, P.Geusens, M.Karperien, F.Vanhoenacker, L.Verbruggen, E.Fransen, J.Van Offel, S.Goemaere, H.G.Zmierczak, R.Westhovens, J.P.Devogelaer, and W.Van Hul (2010).
The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.
  Hum Genet, 128, 615-626.  
19067022 A.Falchetti, M.Di Stefano, F.Marini, S.Ortolani, M.F.Ulivieri, S.Bergui, L.Masi, C.Cepollaro, M.Benucci, O.Di Munno, M.Rossini, S.Adami, A.Del Puente, G.Isaia, F.Torricelli, and M.L.Brandi (2009).
Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone.
  Calcif Tissue Int, 84, 20-37.  
  19789381 A.Kontrogianni-Konstantopoulos, M.A.Ackermann, A.L.Bowman, S.V.Yap, and R.J.Bloch (2009).
Muscle giants: molecular scaffolds in sarcomerogenesis.
  Physiol Rev, 89, 1217-1267.  
19765191 J.Gal, A.L.Ström, D.M.Kwinter, R.Kilty, J.Zhang, P.Shi, W.Fu, M.W.Wooten, and H.Zhu (2009).
Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism.
  J Neurochem, 111, 1062-1073.  
17932931 C.L.Evans, J.E.Long, T.R.Gallagher, J.D.Hirst, and M.S.Searle (2008).
Conformation and dynamics of the three-helix bundle UBA domain of p62 from experiment and simulation.
  Proteins, 71, 227-240.
PDB code: 2k0b
  18645607 F.R.Stoddard, A.D.Brooks, B.A.Eskin, and G.J.Johannes (2008).
Iodine alters gene expression in the MCF7 breast cancer cell line: evidence for an anti-estrogen effect of iodine.
  Int J Med Sci, 5, 189-196.  
18543015 P.Y.Chung, G.Beyens, N.Guañabens, S.Boonen, S.Papapoulos, M.Karperien, M.Eekhoff, L.Van Wesenbeeck, K.Jennes, P.Geusens, E.Offeciers, J.Van Offel, R.Westhovens, H.Zmierczak, J.P.Devogelaer, and W.Van Hul (2008).
Founder effect in different European countries for the recurrent P392L SQSTM1 mutation in Paget's Disease of Bone.
  Calcif Tissue Int, 83, 34-42.  
17129171 C.Collet, L.Michou, M.Audran, S.Chasseigneaux, P.Hilliquin, T.Bardin, I.Lemaire, F.Cornélis, J.M.Launay, P.Orcel, and J.L.Laplanche (2007).
Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations.
  J Bone Miner Res, 22, 310-317.  
17679095 P.Peschard, G.Kozlov, T.Lin, I.A.Mirza, A.M.Berghuis, S.Lipkowitz, M.Park, and K.Gehring (2007).
Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.
  Mol Cell, 27, 474-485.
PDB codes: 2ooa 2oob
16932700 A.Daroszewska, and S.H.Ralston (2006).
Mechanisms of disease: genetics of Paget's disease of bone and related disorders.
  Nat Clin Pract Rheumatol, 2, 270-277.  
16421449 E.D.Lowe, N.Hasan, J.F.Trempe, L.Fonso, M.E.Noble, J.A.Endicott, L.N.Johnson, and N.R.Brown (2006).
Structures of the Dsk2 UBL and UBA domains and their complex.
  Acta Crystallogr D Biol Crystallogr, 62, 177-188.
PDB codes: 2bwb 2bwe 2bwf
16691492 J.R.Cavey, S.H.Ralston, P.W.Sheppard, B.Ciani, T.R.Gallagher, J.E.Long, M.S.Searle, and R.Layfield (2006).
Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone.
  Calcif Tissue Int, 78, 271-277.  
  16877352 K.H.Yip, H.Feng, N.J.Pavlos, M.H.Zheng, and J.Xu (2006).
p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
  Am J Pathol, 169, 503-514.  
17047309 M.W.Wooten, X.Hu, J.R.Babu, M.L.Seibenhener, T.Geetha, M.G.Paine, and M.C.Wooten (2006).
Signaling, Polyubiquitination, Trafficking, and Inclusions: Sequestosome 1/p62's Role in Neurodegenerative Disease.
  J Biomed Biotechnol, 2006, 62079.  
16731964 Y.G.Chang, A.X.Song, Y.G.Gao, Y.H.Shi, X.J.Lin, X.T.Cao, D.H.Lin, and H.Y.Hu (2006).
Solution structure of the ubiquitin-associated domain of human BMSC-UbP and its complex with ubiquitin.
  Protein Sci, 15, 1248-1259.
PDB codes: 2cwb 2den
16277682 A.Falchetti, M.Di Stefano, F.Marini, F.Del Monte, A.Gozzini, L.Masi, A.Tanini, A.Amedei, A.Carossino, G.Isaia, and M.L.Brandi (2005).
Segregation of a M404V mutation of the p62/sequestosome 1 (p62/SQSTM1) gene with polyostotic Paget's disease of bone in an Italian family.
  Arthritis Res Ther, 7, R1289-R1295.  
15837191 A.Ohno, J.Jee, K.Fujiwara, T.Tenno, N.Goda, H.Tochio, H.Kobayashi, H.Hiroaki, and M.Shirakawa (2005).
Structure of the UBA domain of Dsk2p in complex with ubiquitin molecular determinants for ubiquitin recognition.
  Structure, 13, 521-532.
PDB code: 1wr1
  15690073 G.D.Roodman, and J.J.Windle (2005).
Paget disease of bone.
  J Clin Invest, 115, 200-208.  
16138082 J.F.Trempe, N.R.Brown, E.D.Lowe, C.Gordon, I.D.Campbell, M.E.Noble, and J.A.Endicott (2005).
Mechanism of Lys48-linked polyubiquitin chain recognition by the Mud1 UBA domain.
  EMBO J, 24, 3178-3189.
PDB code: 1z96
15953362 J.R.Babu, T.Geetha, and M.W.Wooten (2005).
Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation.
  J Neurochem, 94, 192-203.  
15765181 J.R.Cavey, S.H.Ralston, L.J.Hocking, P.W.Sheppard, B.Ciani, M.S.Searle, and R.Layfield (2005).
Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations.
  J Bone Miner Res, 20, 619-624.  
16313353 L.A.Ehrlich, and G.D.Roodman (2005).
The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma.
  Immunol Rev, 208, 252-266.  
16007098 S.Raasi, R.Varadan, D.Fushman, and C.M.Pickart (2005).
Diverse polyubiquitin interaction properties of ubiquitin-associated domains.
  Nat Struct Mol Biol, 12, 708-714.  
15146436 E.W.Eekhoff, M.Karperien, D.Houtsma, A.H.Zwinderman, C.Dragoiescu, A.L.Kneppers, and S.E.Papapoulos (2004).
Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations.
  Arthritis Rheum, 50, 1650-1654.  
15176995 L.J.Hocking, G.J.Lucas, A.Daroszewska, T.Cundy, G.C.Nicholson, J.Donath, J.P.Walsh, C.Finlayson, J.R.Cavey, B.Ciani, P.W.Sheppard, M.S.Searle, R.Layfield, and S.H.Ralston (2004).
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.
  J Bone Miner Res, 19, 1122-1127.  
15340068 M.L.Seibenhener, J.R.Babu, T.Geetha, H.C.Wong, N.R.Krishna, and M.W.Wooten (2004).
Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation.
  Mol Cell Biol, 24, 8055-8068.  
15365659 R.Layfield, and L.J.Hocking (2004).
SQSTM1 and Paget's disease of bone.
  Calcif Tissue Int, 75, 347-357.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer